Pathophysiological roles of DUX4 in FSHD1 (Homo sapiens)
From WikiPathways
Description
The transcription factor DUX4 is normally expressed during the 4-cell stage, activating various pathways leading to cleavage. This pathway shows how the abberrant expression of DUX4 in post-embryonic stages leads to several disturbations in skeletal muscle fibers, leading to adverse outcomes such as inflammation, apoptosis, and other processes contributing to facioscapulohumeral muscular dystrophy (FSHD). Low D4Z4 subunit methylation, which is caused either by low amount of D4Z4 subunits combined with a permissive 4q haplotype, or a mutation in genes involved with D4Z4 methylation, results in the expression of DUX4.
Quality Tags
Ontology Terms
Bibliography
View all... |
- Imamachi N, Tani H, Akimitsu N; ''Up-frameshift protein 1 (UPF1): multitalented entertainer in RNA decay.''; Drug Discov Ther, 2012 PubMed Europe PMC Scholia
- Xu, H., Wang, Z., Jin, S., Hao, H., Zheng, L., Zhou, B., Zhang, W., Lv, H., Yuan, Y.; ''Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression''; https://doi.org/10.1016/j.bbrc.2014.02.105, 2014 PubMed Europe PMC Scholia
- Teresa Schätzl, Lars Kaiser, Hans-Peter Deigner; ''Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update''; , 2021 PubMed Europe PMC Scholia
- Zoltan Arany, Shi-Yin Foo, Yanhong Ma, Jorge L Ruas, Archana Bommi-Reddy, Geoffrey Girnun, Marcus Cooper, Dina Laznik, Jessica Chinsomboon, Shamina M Rangwala, Kwan Hyuck Baek, Anthony Rosenzweig, Bruce M Spiegelman; ''HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha''; , 2008 PubMed Europe PMC Scholia
- Block GJ, Narayanan D, Amell AM, Petek LM, Davidson KC, Bird TD, Tawil R, Moon RT, Miller DG; ''Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells.''; Hum Mol Genet, 2013 PubMed Europe PMC Scholia
- Mul K, Horlings CGC, Voermans NC, Schreuder THA, van Engelen BGM; ''Lifetime endogenous estrogen exposure and disease severity in female patients with facioscapulohumeral muscular dystrophy.''; Neuromuscul Disord, 2018 PubMed Europe PMC Scholia
- Kenji Rowel Q. Lim, Quynh Nguyen, Toshifumi Yokota; ''DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy''; , 2020 PubMed Europe PMC Scholia
- Teveroni E, Pellegrino M, Sacconi S, Calandra P, Cascino I, Farioli-Vecchioli S, Puma A, Garibaldi M, Morosetti R, Tasca G, Ricci E, Trevisan CP, Galluzzi G, Pontecorvi A, Crescenzi M, Deidda G, Moretti F; ''Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity.''; J Clin Invest, 2017 PubMed Europe PMC Scholia
- Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA; ''Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.''; PLoS One, 2009 PubMed Europe PMC Scholia
- Fiorini F, Bagchi D, Le Hir H, Croquette V; ''Human Upf1 is a highly processive RNA helicase and translocase with RNP remodelling activities.''; Nat Commun, 2015 PubMed Europe PMC Scholia
- Oliva, J., Galasinski, S., Richey, A., Campbell, AE., Meyers, M. J., Modi, N., Zhong, J. W., Tawil, R., Tapscott, S. J., Sverdrup, F. M; ''Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy''; 10.1124/jpet.119.259663, 2019 PubMed Europe PMC Scholia
- Shadle, S.C., Zhong, J.W., Campbell, A.E., Conerly, M.L., Jagannathan, S.; ''DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy''; PLOS Genetics, 2017
- Bosnakovski, D., Gearhart, M.D., Toso, E.A.; ''Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression.''; Sci Rep, 2018
- Vanderplanck C, Ansseau E, Charron S, Stricwant N, Tassin A, Laoudj-Chenivesse D, Wilton SD, Coppée F, Belayew A; ''The FSHD atrophic myotube phenotype is caused by DUX4 expression.''; PLoS One, 2011 PubMed Europe PMC Scholia
- Bosnakovski D, Toso EA, Hartweck LM, Magli A, Lee HA, Thompson ER, Dandapat A, Perlingeiro RCR, Kyba M; ''The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain.''; J Cell Sci, 2017 PubMed Europe PMC Scholia
- Knopp P, Krom YD, Banerji CR, Panamarova M, Moyle LA, den Hamer B, van der Maarel SM, Zammit PS; ''DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis.''; J Cell Sci, 2016 PubMed Europe PMC Scholia
- Bosnakovski, D., Gearhart, M.D., Toso, E.A.; ''Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression''; Nature, 2018
- Shadle, S.C., Zhong, J.W., Campbell, A.E., Conerly, M.L., Jagannathan, S.; ''DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy''; Plos Genetics, 2017
- Banerji CR, Knopp P, Moyle LA, Severini S, Orrell RW, Teschendorff AE, Zammit PS; ''β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.''; J R Soc Interface, 2015 PubMed Europe PMC Scholia
- Resnick, R, Wong, C.J., Hamm, D.C., Bennett, S.R., Skene, P.J., Hake, S.B., Henikoff, S.J.; ''DUX4-Induced Histone Variants H3.X and H3.Y Mark DUX4 Target Genes for Expression''; https://pubmed.ncbi.nlm.nih.gov/31722199/, 2019 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
ADRB2 | GeneProduct | 154 (Entrez Gene) ![]() | |
BMP pathway | Pathway | WP211 (WikiPathways) ![]() | |
CDKN1A | GeneProduct | 1026 (Entrez Gene) ![]() | |
DUX4 | GeneProduct | 100288687 (Entrez Gene) ![]() | |
E2 | Metabolite | CHEBI:23965 (ChEBI) ![]() | |
ESR2 | GeneProduct | 2100 (Entrez Gene) ![]() | |
H3.X | GeneProduct | ENSG00000268799 (Ensembl) ![]() | |
H3.Y | GeneProduct | ENSG00000269466 (Ensembl) ![]() | |
JNK pathway | Pathway | WP1047 (WikiPathways) ![]() | |
MAFbx | GeneProduct | 114907 (Entrez Gene) ![]() | |
MURF1 | GeneProduct | 84676 (Entrez Gene) ![]() | |
MYC | GeneProduct | 4609 (Entrez Gene) ![]() | |
MYF5 | GeneProduct | 4617 (Entrez Gene) ![]() | |
MYOD1 | GeneProduct | 4654 (Entrez Gene) ![]() | |
MYOG | GeneProduct | 4656 (Entrez Gene) ![]() | |
P300 | GeneProduct | 2033 (Entrez Gene) ![]() | |
P53 pathway | Pathway | WP2902 (WikiPathways) ![]() | |
PAX7 | GeneProduct | ENSG00000009709 (Ensembl) ![]() | |
PGC1A | GeneProduct | 10891 (Entrez Gene) ![]() | |
RET | GeneProduct | 5979 (Entrez Gene) ![]() | |
TNF-A pathway | Pathway | WP1047 (WikiPathways) ![]() | |
UPF1 | GeneProduct | 5976 (Entrez Gene) ![]() | |
Unknown | |||
VEGFA | GeneProduct | 7422 (Entrez Gene) ![]() | |
Wnt signaling | Pathway | WP428 (WikiPathways) ![]() | |
cAMP | Metabolite | CHEBI:17489 (ChEBI) ![]() | |
p38 MAPK pathway | Pathway | WP400 (WikiPathways) ![]() |
Annotated Interactions
No annotated interactions